115 results about "Emu oil" patented technology

A liquid composition applied transdermally for relief of pain comprising alcohol in an amount by weight of about 57 to about 91 percent; glycerin in an amount by weight of about 1 to about 12 percent; an analgesic agent in an amount by weight of about 2 to about 28 percent, the analgesic agent comprising a derivative of salicylic acid; methylsulfonylmethane in an amount by weight of about 0.02 to 5 percent; and emu oil in an amount by weight of about 0.01 to 3 percent, the liquid composition permeating skin to relieve pain. The composition further comprising, as an additional feature, aloe vera in an amount by weight of at least about 0.05 percent and having an amount by weight of about 0.05 to 4 percent. The composition features transdermal pain relief such that a patient can apply the analgesic agent directly to an area of pain without such side effects as stomach irritation which is normally associated with aspirin. The composition may be sprayed or rolled directly onto the painful area. Because of the unique formula, the composition is safe to vital internal organs, requires no mixing before use, and is shelf stable for marketing purposes.

The instant invention is directed toward a dermal delivery system composition comprising an aqueous base vehicle including American Emu oil, Isopropyl Palmitate (PROTACHEM IPP), PEG-8 (a polyethylene glycol available under the tradename PROTACHEM 400), methylsulfonylmethane (MSM) and SEPIGEL 305 (a combination including polyacrylamide / C13-C-Iso-paraffin and LAURETH 7, in combination with a therapeutically effective amount of at least one species of insulin, and to processes for the manufacture and use thereof.

A probiotic enzyme ecological-restoration composition uses centella asiatica as a main raw material, uses multiple Chinese herbal medicines including angelica sinensis and the like and food materials as auxiliary materials and is prepared by performing aerobic fermentation and anaerobic fermentation, adding filtrate emu oil, badger oil and horse oil and performing homogeneous processing. The probiotic enzyme ecological-restoration composition can expand the intercellular space of the skin, dredge pores and loosen sweat ducts, promotes the skin to absorb a large amount of beneficial nutritional substances in the composition so as to play the special effects of modification, moisture preserving, moisturizing and immunity enhancement, can rapidly repair the skin, has the obvious effect on scalds, wound infection and scar repair and can also serve as a daily skin care products.

An animal-derived lipid is disclosed that is useful as a carrying agent for anti-microbial formulations. Pharmaceutical and other preparations including Emu Oil are also described as profoundly useful components in anti-bacterial, anti-fungal, and anti-viral treatments. This lipid material is extracted from the Emu (Dromais Novae-Hollandiae), an indigenous bird of Australia and New Zealand. The present invention also discloses therapeutic compositions comprising Emu Oil in combination with an extracellular product of Bacillus coagulans or Pseudomonas lindbergii strain, comprising a supernatant or filtrate of said culture suitable for topical application to the skin or mucosal membranes of a mammal, which are utilized to inhibit the growth of bacterium, yeast, fungi, virus, and combinations thereof. Additionally, the aforementioned therapeutic composition may also include an anti-microbial, anti-mycotic, and / or anti-viral agent. The present invention also discloses methods of treatment and therapeutic systems for inhibiting the growth of bacterium, yeast, fungi, virus, and combinations thereof, by topical application of therapeutic compositions comprising Emu Oil in combination with an extracellular product of Bacillus coagulans or Pseudomonas lindbergii strain suitable for topical application to the skin or mucosal membranes of a mammal. Similarly, the aforementioned method may also employ a therapeutic composition additionally containing an anti-microbial, anti-mycotic, and / or anti-viral agent.

The instant invention is directed toward a dermal delivery system composition comprising an aqueous base vehicle including Emu oil, at least one fatty acid alkyl ester, polyethylene glycol, and a gelling agent, in combination with a therapeutically effective amount of at least one species of insulin, and to processes for the manufacture and use thereof.

emollient and methyl salicylate, where said methyl salicylate comprises between 10 and 30 percent by weight of said cream; a skin stimulant comprising menthol crystals and two or more reactants selected from a group of camphor, cinnamomum cassia, diclofenac, eucalyptus, and ginger to cause a hot and cool stimulus on an epidermal surface; a pain reliever comprising two or more agents selected from a group of benzocaine, emu oil, eucalyptus oil, methylsulfonylmethane and glucosamine; and an inflammatory comprising two or more agents selected from a group of artemisia vulgaris, amica Montana flower extract, licorice root extract, oat extract, and thyme oil.

The skin care composition is a cream or lotion that moisturizes the skin, relieving dryness, itchiness, and eczema. The skin care composition contains moisturizers and a plurality of natural oils containing essential fatty acids, the natural oils being selected from the group consisting of borage oil, omega-3 oil, emu oil, evening primrose oil, safflower oil, hemp seed oil, flaxseed oil, and rosehip oil. The moisturizers include olive oil and glycerin. In addition, the skin care composition contains an anti-inflammatory agent, preferably aloe vera juice and aloe extract, and emulsifiers, stabilizers, emollients for softening the skin, and water. The skin care composition may also contain a fragrance and a preservative. Optionally, the skin care composition may contain menthol crystal.

The present invention relates to pharmaceutical compositions comprising ester(s) of capsaicin and at least one other agent selected from salicylates, menthol, boswellic acids, DMSO, methyl sulfonylmethane, NSAIDs, corticosteroids, emu oil, opioid agonists and antagonists, NMDA antagonists, tramadol, hyaluronic acid, α2δ ligands, santalol, santalyl acetate, amyris alcohol, amyris acetate, aloe vera gel and aloe vera juice, for improved therapeutic properties. Further, the present invention relates to pharmaceutical compositions comprising high concentrations of ester(s) of capsaicin. Further, the present invention relates to a method of relieving pain due to various diseases in subjects by administering the pharmaceutical compositions of the invention. Further, the present invention relates to methods of relieving fever blisters due to cold sores in subjects by administering the pharmaceutical compositions comprising an ester of capsaicin and one other agent selected from santalol, santalyl acetate, amyris alcohol and amyris acetate.

A medicament for the treatment of inflammatory and non-inflammatory arthritis that includes the following ingredients: arnica, calendula, glucosamine, salicylic acid, hamamelis, emu oil and wild yam. The medicament may be in the form of an ointment, cream, gel, emulsion or liquid solution that is topically applied directly to the affected area. Alternatively, a pad saturated with the medicament having self adhesive qualities that may be placed directly on the affected area may be used. Additionally, the medicament may be applied directly on the affected area or a pad saturated with the medicament is applied to the affected area, and then the area is wrapped with a sleeve or band.

This invention relates to a composition of matter for producing hair growth and preventing hair loss in humans and the method for using said composition. The composition comprises four complexes and a carrier liquid, mixed together and added to any topical treatment or produced as an ingestible dietary supplement. Complexes 1, 2, and 3 are comprised of substances that prevent hair loss while Complex 4 promotes hair growth. Complex 1 is comprised of octyl butyrate and glutaminpeptides. Complex 2 comprises a mixture of minerals, plant extracts, vitamin B6, and linolenic acid. Complex 3 comprises a mixture of Ginkgo biloba extract, emu oil, a source of silicon, and a blend of amino acids. Complex 4 comprises a mixture of several plant extracts. The product should be used by the consumer at regular intervals, preferably 5 to 7 times per week in the form of a serum.

The invention provides topical compositions and methods for using the compositions. The compositions can be used for the treatment of fibrotic or connective tissue disorders involving scarring, sub-dermal plaque accumulations, or fibrosis of muscle tissue. The disorders can be painlessly treated by the topical application of a composition described herein. One or more calcium channel blocker agents can serve as an active ingredient of the compositions, optionally in combination with, for example, one or more of emu oil and superoxide dismutase. The composition can further include pharmaceutically acceptable carriers that can facilitate the non-invasive transdermal delivery of the active(s) to subdermal sites.

The invention discloses a traditional Chinese medicine preparation for treating alopecia and a preparation method thereof. The traditional Chinese medicine preparation for treating alopecia of the invention is prepared from the following medicinal materials of, by weight, main drugs comprising 12-18 parts of angelica sinensis, 8-12 parts of radix rehmanniae recen, 8-12 parts of fructus ligustri lucidi, 8-12 parts of semen cuscutae, 8-12 parts of matrimony vine, 4-6 parts of Chinese honey locust, 12-18 parts of polygonum multiflorum, 8-12 parts of semen sesami nigrum, 8-12 parts of ginger, 4-6parts of eclipta, 8-12 parts of cacumen biotae, 12-18 parts of mulberry, 8-12 parts of fructus cnidiiand, and 3-5 parts of borneol, and adjuvants of emu oil and alligator oil, wherein mass concentration of emu oil in the traditional Chinese medicine preparation is 4%-6%, and mass concentration of alligator oil in the traditional Chinese medicine preparation is 6%-8%. The preparation of the invention has efficacies of tonifying qi and nourishing the blood, promoting blood circulation and removing blood stasis, stimulating the menstrual flow and promoting blood circulation, breeding and nourishing hair, dispelling wind and arresting itching, activating occlusive hair follicle, and promoting hair regeneration. In addition, inflammation of scrubbing place can be avoided, and scar and ecchymosis formation rate is low.

A composition is provided comprising emu oil and processed whole fruit. The composition is in a form for either topical application to human skin or for internal ingestion.

A topical pharmaceutical preparation suitable for use as an antihistamine or anti-nausea drug comprises an emu oil gel base and a therapeutic amount of promethazine.HCl. The preparation may further comprise an antioxidant. The preparation is preferably packaged as a single unit dose. A method for preparing the topical pharmaceutical preparation comprises the steps of combining a clear gel with an emu oil mixture and adding a therapeutic amount of promethazine.HCl solution.

The invention provides a compound grease microemulsion used in cosmetics and a preparation method thereof. The microemulsion is prepared by raw materials including compound grease, a surfactant and water, wherein the weight ratio of the compound grease, the surfactant and the water is 1:3-10:20-100; and the compound grease is a mixture of emu oil, mimusops elengi tree fruit oil, tea tree oil and vitamin E. The compound grease microemulsion is transparent or translucent in appearance, the average particle size is less than 100nm, the stability of the grease is enhanced, the compatibility of the grease with water-soluble substances is improved, and the compound grease microemulsion can be used in various skin care products and cleaning and nursing supplies, and is especially applicable to products in a transparent system.

The present invention provides a novel scientific approach to determine whether a compound has anti-inflammatory activity. In particular, the novel assays allow the screening of compounds for the purposes of prophylactic and therapeutic use in treating or ameliorating the symptoms of T-cell, macrophage or neutrophil mediated diseases in mammals. In particular, the invention is based on the measurement of the capacity of a substance being an oil or fat, an alcoholic extract of an oil or fat, a biologically active component of an oil or a fat, or a preparation comprising an oil or fat, to suppress the activity of T-cells, macrophages or neutrophils in humans or animals in response to chemical and / or biological agents that activate these cell types. Measurements are made either in vivo (eg in mice) or in an in vitro preparation of human T-cells, macrophages or neutrophils, or a cell line derived therefrom. The substance is, in particular, emu oil or an ethanolic extract thereof. Therapeutic compositions and methods are also disclosed.

An antimicrobial and antiviral barrier composition for topical application to the proximal anterior nares includes an antiseptic solution in combination with cocos nucifera (coconut oil) and one or more citrus oils such as, for example, citrus sinensis (orange oil). Various embodiments may also include one or more of the following additional ingredients: lauric acid; d-limonene; soy oil; emu oil; grapefruit seed extract; glycine soja; simmondsia chimensis (Jojoba); aloe vera; and a preservative, such as sodium benzoate, BHT, benzalkonium chloride, vitamin E.

The instant invention discloses a dermal delivery system composition comprising an aqueous base vehicle including American Emu oil, Isopropyl Palmitate (PROTACHEM IPP), PEG-8 (a polyethylene glycol available under the trade name PROTACHEM 400), methylsulfonylmethane (MSM) and SEPIGEL 305 (a combination including polyacrylamide / C13–C14 Iso-paraffin and Laureth-7) in combination with a therapeutically affective amount of at least one species of insulin, and to processes for the manufacture and use thereof.

An antimicrobial and antiviral barrier composition for topical application to the proximal anterior nares includes an antiseptic solution in combination with cocos nucifera (coconut oil) and one or more citrus oils such as, for example, citrus sinensis (orange oil). Various embodiments may also include one or more of the following additional ingredients: lauric acid; d-limonene; soy oil; emu oil; grapefruit seed extract; glycine soja; aloe vera and a preservative, such as sodium benzoate.

The invention discloses emulsion containing traditional Chinese medicine extracting solution and used for treating eczema and a preparation method thereof. According to the formula, the emulsion comprises sweet almond oil, calamine, evening primrose oil, comfrey infused oil, emu oil, a rhizoma chuanxiong extracting solution, a cortex phellodendri extracting solution, a radix sophorae flavescentis extracting solution, a rough gentian extracting solution, a cortex dictamni extracting solution, a common cnidium fruit extracting solution, a cell activating agent MG-60, water-soluble VE, glycerol, 1,2-propylene glycol, ethylparaben, sodium alginate, Creagel SC G57 and distilled water. Compared with the prior art, the emulsion is gentle in medicine property and high in safety. Active substances in natural traditional Chinese medicine are adopted for promoting healthy growth of skin, the normal barrier function of the skin is restored, inflammatory cells can be inhibited, the emulsion is antibacterial and can expel toxin, superficial cells of the skin are adjusted, and elasticity of the skin is restored; the emulsion further has the functions of calming down the nerves and relieving itching, eliminating redness and swollenness, relaxing the skin surface layer and relieving skin scars and has the curative effect of remarkably relieving eczema.

The instant invention is directed toward a dermal delivery system composition comprising an aqueous base vehicle including American Emu oil, Isopropyl Palmitate (PROTACHEM IPP), PEG-8 (a polyethylene glycol available under the tradename PROTACHEM 400), methylsulfonylmethane (MSM) and SEPIGEL 305 (a combination including polyacrylamide / C13-C14 Iso-paraffin and LAURETH 7, in combination with an analgesic composition, such as ibuprofen, and to processes for the manufacture and use thereof.

A transcutaneous pain relief composition for applying to the skin, comprising a mixture of dimethyl sulfoxide, stearic acid, emulsifying wax, glycerine, emu oil, sal butter, glucosamine, coconut oil, white beeswax, active calendula oil, slippery elm oil, Chamomile oil, arnica Oil, valenrian oil, peppermint oil, grapefruit seed extract, lavender oil and distilled water is disclosed.

A repairing emu fat cream is proporionally prepared from emu fat, the extract of arnebia root, emu collagen peptide, antioxidant and emulsifier through pulverizing the extract of arnebia root to obtain micron-class particles, proportionally mixing with others, heating to 80-85 deg.C, high-speed homogenizing, and cooling.

A nano-liposome of emu fat in the form of transparent liquid is prepared from emu fat, lecithin, cholesterol, antioxidant, solubilizer, thickening agent and glycerin through proportioning, preparing oil phase and water phase, mixing, filling N2 to prepare dispersed emulsion, filling N2 while high-pressure homogenizing, and natural cooling.

An animal-derived lipid is disclosed that is useful as a carrying agent for anti-microbial formulations. Pharmaceutical and other preparations including Emu Oil are also described as profoundly useful components in anti-bacterial, anti-fungal, and anti-viral treatments. This lipid material is extracted from the Emu (Dromais Novae-Hollandiae), an indigenous bird of Australia and New Zealand. The present invention also discloses therapeutic compositions comprising Emu Oil in combination with an extracellular product of Bacillus coagulans or Pseudomonas lindbergii strain, comprising a supernatant or filtrate of said culture suitable for topical application to the skin or mucosal membranes of a mammal, which are utilized to inhibit the growth of bacterium, yeast, fungi, virus, and combinations thereof. Additionally, the aforementioned therapeutic composition may also include an anti-microbial, anti-mycotic, and / or anti-viral agent. The present invention also discloses methods of treatment and therapeutic systems for inhibiting the growth of bacterium, yeast, fungi, virus, and combinations thereof, by topical application of therapeutic compositions comprising Emu Oil in combination with an extracellular product of Bacillus coagulans or Pseudomonas lindbergii strain suitable for topical application to the skin or mucosal membranes of a mammal. Similarly, the aforementioned method may also employ a therapeutic composition additionally containing an anti-microbial, anti-mycotic, and / or anti-viral agent.

The invention discloses a scar and pockmark removing lotion rich in natural extracts and a preparation method of the lotion. The lotion is prepared from aloe oil, almond oil, marigold oil, sea buckthorn oil, horse oil, emu oil, glycerol, a 1% sodium hyaluronate solution, a radix salvia miltiorrhiza extracting solution, a white muscardine silkworm extracting solution, a peach seed extracting solution, a herba centellae extracting solution, D-panthenol, an ML emulsifying agent, an olive emulsifying agent, distilled water, silicone oil, sodium alginate, cationic guar gum, a compound antibacterial agent and essence. Compared with the prior art, the lotion is faint yellow, appropriate in thickness, light and hydrated, fine, smooth and uniform, good in spreadability, fragrant in smell and green and purely natural in effective ingredient, the contained sodium hyaluronate has the softening and scar forming preventing functions, and the effective ingredients can go deep into the dermis to decompose, remove and replace various aged, fibrotic, damaged and non-functional scar tissue and prepare a space for epithelial cells with the regeneration potential.

A method of reducing the number of microorganisms entering the nose and proliferating in the nasal cavity including application of a solution of an antimicrobial, antiviral and antifungal composition to the anterior vestibular region of the nares. The antimicrobial, antiviral and antifungal solution includes ethyl alcohol as an active ingredient. Various embodiments may also include one or more of the following additional ingredients: orange oil, coconut oil; soy oil; emu oil; grapefruit seed extract; glycine soja; simmondsia chinensis (Jojoba); lauric acid; aloe vera; and a preservative, such as benzalkonium chloride and vitamin E.

The invention discloses a viscometer used for measuring viscosity of emu oil. The viscometer comprises a box body with an open-ended upper part, a plurality of finer wire parallely and fixedly arranged at an opening of the box body at intervals and a temperature sensor arranged at one side of the finer wire, wherein gaps between every two adjacent finer wires increasingly decrease, two ends of each of the finer wires are respectively provided with a calibrated viscosity value, a magnifier is arranged above each viscosity value, and the temperature sensor comprises a temperature sensing terminal arranged at an outermost or innermost side of the finer wires and a display fixedly arranged on the box body for displaying of temperature. The viscometer provided by the invention has a simple structure, is convenient to use, ensures viscosity testing and accurately provides temperature information; the position between two finer wires allowing the emu oil to be barely stored represents viscosity of the emu oil, and the greater the viscosity is, the larger the gap between the two finer wires is. The advantages of simple overall operation, no waste, improved testing efficiency and reduced test cost are obtained in the invention.